| J9271 | Injection, pembrolizumab, 1 mg | 10,800 | $40 | $464.4K |
| J0897 | Injection, denosumab, 1 mg | 9,960 | $20 | $179.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $110 | $56.2K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 20,300 | $1 | $40.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 40,500 | $1 | $40.5K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 490 | $70 | $36.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 260 | $120 | $32.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 170 | $160 | $26.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 220 | $80 | $16.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 160 | $60 | $9.7K |